Genetic testing for Parkinson's disease: Indication and practical implementation

Tönges L, Ip CW, Dresel C, Lingor P, Csoti I, Kohl Z, Winkler J, Klebe S (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Fortschritte der Neurologie - Psychiatrie Georg Thieme Verlag

DOI: 10.1055/a-1155-6389

Abstract

More than 20 years have passed since the first description of a monogenic cause of Parkinson's disease. Despite the tremendous advances of genetic testing these techniques are rarely used in Parkinson's disease. However, genetic tests in patients with Parkinson's syndrome will play an important role in the future. This is not only to ensure the diagnosis of Parkinson's patients with a young onset and/or a positive family history, but also in the context of personalised medicine with new therapeutic options. In the following we would like to give an overview of the basics of genetic testing, the legal requirements, the procedure for genetic testing and an outlook into the future for hereditary Parkinson's diseases.

Authors with CRIS profile

Jürgen Winkler Professur für Molekulare Neurologie

Involved external institutions

Ruhr-Universität Bochum (RUB) DE Germany (DE) Universität Regensburg DE Germany (DE) Universitätsklinikum Essen DE Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz DE Germany (DE) Klinikum rechts der Isar DE Germany (DE)

How to cite

APA:

Tönges, L., Ip, C.W., Dresel, C., Lingor, P., Csoti, I., Kohl, Z.,... Klebe, S. (2020). Genetic testing for Parkinson's disease: Indication and practical implementation. Fortschritte der Neurologie - Psychiatrie. https://doi.org/10.1055/a-1155-6389

MLA:

Tönges, Lars, et al. "Genetic testing for Parkinson's disease: Indication and practical implementation." Fortschritte der Neurologie - Psychiatrie (2020).

BibTeX: Download